By Natalie Rodriguez ( March 15, 2012, 6:10 PM EDT) -- British pharmaceutical giant GlaxoSmithKline PLC has agreed to sell six European over-the-counter drug brands and a manufacturing plant to Omega Pharma for €470 million ($613.6 million), in a continued effort to lighten itself of noncore assets, GSK said Thursday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.